RIPK1 autophosphorylation at S161 mediates cell death and inflammation

Area of Science:

• Molecular Biology
• Immunology
• Cell Biology

Background:

• Receptor-interacting protein kinase 1 (RIPK1) is a key regulator of programmed cell death and inflammatory signaling.
• The precise mechanisms of RIPK1 autophosphorylation and the roles of specific phosphorylation sites in its function remain largely unknown.
• Dysregulation of RIPK1 is implicated in various inflammatory diseases.

Purpose of the Study:

• To elucidate the physiological function of RIPK1 autophosphorylation at specific sites, particularly S161.
• To investigate the role of S161 autophosphorylation in RIPK1-mediated cell death and inflammation.
• To understand the interplay between different RIPK1 phosphorylation sites.

Main Methods:

• Generation and utilization of knock-in mouse models with specific RIPK1 mutations (S161N, S166A, S161E).
• Assessment of RIPK1 catalytic activity and cell death induction (necroptosis, apoptosis) in response to mutations.
• Evaluation of skin inflammation in mouse models under conditions of RIPK1-mediated cell death.

Main Results:

• S161 autophosphorylation was identified as critical for RIPK1-mediated cell death and inflammation.
• S161N substitution partially impaired RIPK1 catalytic activity and cell death but effectively prevented skin inflammation.
• Combined S161N and S166A mutations showed synergistic effects in preventing RIPK1-mediated cell death, indicating functional redundancy.
• Phosphomimetic S161E mutation demonstrated sufficiency for necroptosis induction, even overriding the inhibitory effect of S166A mutation.

Conclusions:

• RIPK1 S161 autophosphorylation is a critical regulator of RIPK1-dependent cell death and inflammatory responses.
• A functional interplay between S161 and S166 phosphorylation sites governs RIPK1 activity and downstream signaling.
• Targeting RIPK1 phosphorylation, specifically at S161, holds potential for therapeutic intervention in inflammatory diseases.